Ibai E Valverde Selected Research

Peptides (Polypeptides)

1/2016	Structure-Activity Relationship Studies of Amino Acid Substitutions in Radiolabeled Neurotensin Conjugates.
1/2016	Toward the Optimization of Bombesin-Based Radiotracers for Tumor Targeting.
10/2015	1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting.
9/2015	Probing the Backbone Function of Tumor Targeting Peptides by an Amide-to-Triazole Substitution Strategy.
4/2014	Radiolabeled antagonistic bombesin peptidomimetics for tumor targeting.
10/2012	Dual-targeting conjugates designed to improve the efficacy of radiolabeled peptides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ibai E Valverde Research Topics

Disease

12	Neoplasms (Cancer) 05/2023 - 10/2012
2	Prostatic Neoplasms (Prostate Cancer) 04/2023 - 01/2016
1	Lung Neoplasms (Lung Cancer) 09/2017
1	Insulinoma 10/2015
1	Neoplasm Metastasis (Metastasis) 10/2012

Drug/Important Bio-Agent (IBA)

6	Peptides (Polypeptides)IBA 01/2016 - 10/2012
5	TriazolesIBA 04/2021 - 08/2013
5	AmidesIBA 04/2021 - 08/2013
4	Bombesin Receptors (Bombesin Receptor)IBA 05/2023 - 09/2015
4	BombesinIBA 09/2017 - 04/2014
2	AntigensIBA 05/2023 - 04/2023
2	neurotensin (9-13)IBA 01/2016 - 10/2015
2	NeurotensinIBA 01/2016 - 10/2015
2	PeptidomimeticsIBA 04/2014 - 08/2013
1	LigandsIBA 05/2023
1	minigastrinIBA 04/2021
1	Neprilysin (Neutral Endopeptidase)IBA 09/2017
1	phosphoramidonIBA 09/2017
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 09/2017
1	Chelating AgentsIBA 02/2017
1	Trastuzumab (Herceptin)FDA Link 02/2017
1	Exenatide (Byetta)FDA Link 10/2015
1	Pentetic Acid (DTPA)FDA LinkGeneric 10/2015
1	Peptide Hydrolases (Proteases)FDA Link 08/2013
1	Radioisotopes (Radionuclides)IBA 10/2012

Therapy/Procedure

4	Therapeutics 09/2017 - 10/2012
1	Precision Medicine 04/2023